Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2153 |
1-NM-PP1
PP1 Analog II,1 nM-PP1 |
Serine/threonin kinase; CDK; Src | Angiogenesis; Cell Cycle/Checkpoint; Metabolism; Tyrosine Kinase/Adaptors |
1-NM-PP1 (PP1 Analog II) 是一种有效的Src 家族激酶抑制剂,是一种细胞渗透性 PP1 类似物,对 v-Src-as1 与 c-Fyn-as1 的IC50值分别为 4.3 nM、3.2 nM。 | |||
T79878 |
Hydroxy-PP-Me
|
Apoptosis | Apoptosis |
Hydroxy-PP-Me为一特异性CBR1抑制剂,IC50值为759 nM。该化合物能够抑制血清戒断所诱导的细胞凋亡(apoptosis)。与As2O3单独应用相比,Hydroxy-PP-Me可增强As2O3引发的凋亡细胞死亡效果。 | |||
T74359 | PP-C8 | ||
PP-C8 是一种有效的选择性 PROTACCDK12-Cyclin K 降解剂。PP-C8 诱导 CDK12-Cyclin K 降解,对 CDK12 和 Cyclin K 的DC50分别为 416 和 412 nM。PP-C8 与PARP 抑制剂在三阴性乳腺癌 (TNBC) 中具有高效的协同抗增殖作用。 | |||
T36864 |
GRP (human) (trifluoroacetate salt)
|
||
Gastrin-releasing peptide (GRP) is a neuropeptide that stimulates gastrin release. It binds to (Ki = 300 nM) and stimulates amylase secretion in rat pancreatic AR42J cells (EC50 = 0.3 nM). GRP increases proliferation of human liver carcinoma HepG2 and MHCC97H cells but does not affect the proliferation of normal HL-7702 liver cells at a concentration of 1 nM. In vivo, GRP (0.35 nmol/kg/h) increases both pancreatic exocrine secretion and pancreatic polypeptide (PP) release in rats. It dose-depend... |